Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Mind-body medicine for multiple sclerosis: a systematic review.
The Physical and Psychological Impact of Multiple Sclerosis Using the MSIS-29 via the Web Portal of the UK MS Register.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study.
A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: Changes in health-related quality of life and the value of different factors in predicting health-related quality of life.
Understanding Drivers of Employment Changes in a Multiple Sclerosis Population.
Brain Plasticity Effects of Neuromodulation Against Multiple Sclerosis Fatigue.
Cell fusion in the brain: two cells forward, one cell back.
Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.
Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.
FDA Approves New Drug to Treat Psoriasis
Treatment of cognitive impairment in patients with multiple sclerosis.
Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development.
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.
Effects of fingolimod in relapsing-remitting multiple sclerosis.
JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
Glial influence on the blood brain barrier.
Microsatellite polymorphism in haem oxygenase 1 gene promoter in multiple sclerosis.
Deep-brain stimulation for Parkinson's disease.
The Future of Research in Multiple Sclerosis.
Transcriptional expression of MBP in oligodendrocytes depends on functional syntaxin 4; a potential correlation with autocrine signalling.
Pages
« first
‹ previous
…
264
265
266
267
268
269
270
271
272
…
next ›
last »